US regulators are stepping up efforts to reduce animal use in early drug development. On 18 March 2026, the US Food and Drug Administration issued draft guidance encouraging companies to swap or reduce animal studies where credible human-relevant tools exist. This marks an important recognition of the growing range of animal testing alternatives available to researchers. The FDA says a…